P53 is a known tumor suppressor and mouse models with mutations in the p53 gene are prone to developing spontaneous lymphomas and leukemias, but rarely develop breast cancer, unlike patients with the Li–Fraumeni Syndrome. Here, TP53 is linked to neoplasm.